Molecular characterization of breast cancer cell response to metabolic drugs

Metabolic reprogramming is a hallmark of cancer. It has been described that breast cancer subtypes present metabolism differences and this fact enables the possibility of using metabolic inhibitors as targeted drugs in specific scenarios. In this study, breast cancer cell lines were treated with met...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Oncotarget
Egile Nagusiak: Trilla-Fuertes, Lucía, Gámez-Pozo, Angelo, Arevalillo, Jorge M., Díaz-Almirón, Mariana, Prado-Vázquez, Guillermo, Zapater-Moros, Andrea, Navarro, Hilario, Aras-López, Rosa, Dapía, Irene, López-Vacas, Rocío, Nanni, Paolo, Llorente-Armijo, Sara, Arias, Pedro, Borobia, Alberto M., Maín, Paloma, Feliú, Jaime, Espinosa, Enrique, Fresno Vara, Juan Ángel
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Impact Journals LLC 2018
Gaiak:
Research Paper
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5839391/
https://ncbi.nlm.nih.gov/pubmed/29515760
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.24047
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak